Grupo Biotoscana's IPO

Grupo Biotoscana raised a round of funding on August 22, 2017. Investors include Public.

Grupo Biotoscana (GBIO33) is a pharmaceutical multinational company, provides pharma, biological, hospital, oncological, and generic products.…

Articles about Grupo Biotoscana's IPO: